Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

@article{Dreyling2016NewlyDA,
  title={Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.},
  author={Martin H. Dreyling and Michele Ghielmini and Simon Rule and Gilles A Salles and Umberto Vitolo and Marco Ladetto},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2016},
  volume={27 suppl 5},
  pages={
          v83-v90
        }
}
M. Dreyling1, M. Ghielmini2, R. Marcus3, G. Salles4, U. Vitolo5 & M. Ladetto6 on behalf of the ESMO Guidelines Working Group* Department of Medicine III, University of Munich, Munich, Germany; Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Haematology, Kings College Hospital, London, UK; Service D’Hématologie, Centre Hospitalier Lyon-Sud, Pierre-Benite, France; Haematology II, Centro Universitario Ricerca Oncologica Ospedale Molinette, Turin… CONTINUE READING
Highly Cited
This paper has 210 citations. REVIEW CITATIONS
Related Discussions
This paper has been referenced on Twitter 20 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

Current prognostic and predictive factors in follicular lymphoma

Annals of Hematology • 2017
View 4 Excerpts
Highly Influenced

Infections and Follicular Lymphoma: is there a Link?

Mediterranean journal of hematology and infectious diseases • 2017
View 1 Excerpt

210 Citations

0100200201720182019
Citations per Year
Semantic Scholar estimates that this publication has 210 citations based on the available data.

See our FAQ for additional information.

References

Publications referenced by this paper.
Showing 1-10 of 40 references

Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology • 2015
View 1 Excerpt

Randomized trial of bendamustinerituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study

IW Flinn, R van der Jagt, BS Kahl
Blood • 2014
View 1 Excerpt

The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium

B Sander, D de Jong, A Rosenwald
Haematologica • 2014
View 1 Excerpt

Similar Papers

Loading similar papers…